Atopic Dermatitis
Galderma’s Nemolizumab Approved for AD and PN in the UK and Switzerland
February 18, 2025
Galderma Scores Twin Approvals for Nemolizumab in Europe
February 14, 2025
Research Sheds Light on the Itch Paradox
January 31, 2025
Poster Abstracts
Advertisement
Latest Issue
Latest Supplements
Advertisement
Digital Edition Archive
